Clinical Trial Update: Dose Modification Requirement for Trelagliptin in Egyptian Population [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating dose modification requirements for trelagliptin in the Egyptian population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Trelagliptin (trelagliptin)

Snippet

Sponsor: British University In Egypt | Conditions: Diabetes Mellitus | Phase 4 | Status: UNKNOWN